ACAD · Acadia Pharmaceuticals Inc

$28.24 -0.14 (-0.49%) At close · Aug 14

Market Cap

$4.87B

172.31M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed	Seller	Relationship	Shares	Market Value	Approx. Sale	Broker
2026-08-05	Schneyer Mark C.	Officer	5,849	$158,800	2026-08-05	Piper Sandler & Co Inc
2026-06-26	Kihara James	Officer	11,421	$297,000	2026-06-26	Piper Sandler & Co Inc
2026-05-26	JAMES K KIHARA	Officer	5,401	$114,394	2026-05-26	Morgan Stanley Smith Barney LLC Executive Financial Services
2025-11-10	James M Daly	Director	30,000	$670,983	2025-11-10	Morgan Stanley Smith Barney LLC Executive Financial Services
2025-08-18	Schneyer Mark C.	Officer	22,000	$557,260	2025-08-18	Piper Sandler & Co Inc
2025-06-04	LAURA BREGE	Director	14,446	$314,638	2025-06-04	Morgan Stanley Smith Barney LLC Executive Financial Services
2025-05-16	Schneyer Mark C.	Officer	2,000	$35,200	2025-05-16	Piper Sandler & Co Inc
2025-05-16	Kihara James	Officer	4,000	$70,400	2025-05-16	Piper Sandler & Co
2025-03-06	GAROFALO ELIZABETH A.	Director	4,919	$89,673	2025-03-05	MORGAN STANLEY SMITH BARNEY LLC EXECUTIVE SERVICES
2023-12-15	Kihara James	Officer	2,000	$56,120	2023-12-15	Piper Sandler & Co.
2023-09-15	Kihara James	Officer	2,000	$51,700	2023-09-15	Piper Sandler & Co
2023-08-21	Schneyer Mark C.	Officer	10,000	$293,300	2023-08-21	Piper Sandler & Co.
2023-07-14	DAVIS STEPHEN	Officer, Director	100,000	$2,580,000	2023-07-14	Piper Sandler & Co.
2023-07-13	DAVIS STEPHEN	Officer, Director	71,602	$1,773,582	2023-07-11	Piper Sandler & Co.
2023-06-15	Kihara James	Officer	2,000	$48,280	2023-06-15	Piper Sandler & Co.
2023-06-12	Brege Laura	Director	4,500	$112,240	2023-06-12	Piper Sandler & Co.

Showing 1–16 of 16 filings

Key facts CIK 1070494 CUSIP 004225108 13F (30d) 351 filings 323 filers Visit website Investor relations